<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>index.utf8</title>
    <meta charset="utf-8" />
    <script src="libs/header-attrs-2.7/header-attrs.js"></script>
    <link href="libs/remark-css-0.0.1/default.css" rel="stylesheet" />
    <link href="libs/remark-css-0.0.1/metropolis.css" rel="stylesheet" />
    <link href="libs/remark-css-0.0.1/metropolis-fonts.css" rel="stylesheet" />
    <link href="libs/panelset-0.2.6/panelset.css" rel="stylesheet" />
    <script src="libs/panelset-0.2.6/panelset.js"></script>
  </head>
  <body>
    <textarea id="source">

class: primary

&lt;style type="text/css"&gt;

p.caption {
  font-size: 0.6em;
}

.large { font-size: 200% }

.medium-large { font-size: 130% }

.small{ font-size: 80% }

.cv{ font-size: 60% }

.tiny{ font-size: 40% }

.center-left {
  position:          relative;
  top:               50%;
  transform:         translateY(50%);
}
.center-right {
  position:          relative;
  top:               50%;
  transform:         translateY(10%);
}

.remark-slide-content {
  background-color: #FFFFFF;
  border-top: 80px solid #662e6b;
  font-size: 28px;
  font-weight: 300;
  line-height: 1.5;
  padding: .5em 3em .5em 3em
}

.inverse {
  background-color: #662e6b;
  text-shadow: none;
}

.right-column {
	color: #000000;
	width: 30%;
	height: 92%;
	float: right;
}

.left-column {
  width: 68%;
  float: left;
}

.remark-slide-number {
	display: none;
}

.remark-slide-content:after {
    content: "";
    position: absolute;
    bottom: 0px;
	left: 20px;
    height: 60px;
    width: 400px;
	font-size: 12px;
    background-repeat: no-repeat;
    background-size: contain;
	background-image: url("img/The-Ohio-State-University-Wexner-Medical-Center.png")
}

mark {
  background-color: teal;
  color: white;
}

&lt;/style&gt; 

.pull-left[
&lt;h2 style=font-size:35px&gt; Integrative and Network-Based Approaches for Functional Interpretation of Metabolomic Data&lt;/style&gt;
&lt;h6 style=font-size:20px&gt;
&lt;br&gt;
Andrew Patt, Doctoral Candidate
&lt;br&gt;
&lt;br&gt;
National Center for Advancing Translational Science/The Ohio State University
&lt;/style&gt;
]

.pull-right[
&lt;img src="img/Thesis_schematic.png" width="500px" /&gt;
]





---

# C.V.

.cv[
**B.Sc. Biochemistry, Biomathematics minor (SUNY Geneseo, 2015)**

#### Published

- RaMP: A Comprehensive Relational Database of Metabolomics Pathways
  for Pathway Enrichment Analysis of Genes and Metabolites. 2018,
  Metabolites (*Second author*)
- Integration of Metabolomics and Transcriptomics to Identify
  Gene-Metabolite Relationships Specific to Phenotype. 2019, Methods
  Mol Biol (*First author*)
- Challenges in proteogenomics: a comparison of analysis methods with
  the case study of the DREAM proteogenomics sub-challenge. 2019, BMC
  Bioinformatics (*Co-first author*)
- Metabolomics and Multi-Omics Integration: A Survey of Computational
  Methods and Resources. 2020, Metabolites (*Second author*)
- MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in
  Dedifferentiated Liposarcoma Models. 2020, MDPI Cancers (*Co-first author*)

#### Preprint/ In review
- An OpenData portal to share COVID-19 drug repurposing data in real
  time. 2020, bioRxiv (*Middle author*)
- Lipidomics and Redox Lipidomics Indicate Early-Stage Alcohol-Induced
  Liver Damage. 2021, Hepatology (*In review, Middle author*)

#### Future
- MetaboSPAN: Network-Based Approach for Functional Interpretation
  of Metabolomic Data
- RaMP 2.0: update to the RaMP pathway database
]


---

# C.V.

.cv[
**B.Sc. Biochemistry, Biomathematics minor (SUNY Geneseo, 2015)**

#### Published

- &lt;mark&gt;&lt;b&gt;RaMP: A Comprehensive Relational Database of Metabolomics Pathways
  for Pathway Enrichment Analysis of Genes and Metabolites. 2018,
  Metabolites (&lt;i&gt;Second author&lt;/i&gt;)&lt;/b&gt;&lt;/mark&gt;
- &lt;mark&gt;&lt;b&gt;Integration of Metabolomics and Transcriptomics to Identify
  Gene-Metabolite Relationships Specific to Phenotype. 2019, Methods
  Mol Biol (&lt;i&gt;First author&lt;/i&gt;)&lt;/b&gt;&lt;/mark&gt;
- Challenges in proteogenomics: a comparison of analysis methods with
  the case study of the DREAM proteogenomics sub-challenge. 2019, BMC
  Bioinformatics (*Co-first author*)
- &lt;mark&gt;&lt;b&gt;Metabolomics and Multi-Omics Integration: A Survey of Computational
  Methods and Resources. 2020, Metabolites (&lt;i&gt;Second author&lt;/i&gt;)&lt;/b&gt;&lt;/mark&gt;
- &lt;mark&gt;&lt;b&gt;MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in
  Dedifferentiated Liposarcoma Models. 2020, MDPI Cancers (&lt;i&gt;Co-first author&lt;/i&gt;)&lt;/b&gt;&lt;/mark&gt;

#### Preprint/ In review
- An OpenData portal to share COVID-19 drug repurposing data in real
  time. 2020, bioRxiv (*Middle author*)
- Lipidomics and Redox Lipidomics Indicate Early-Stage Alcohol-Induced
  Liver Damage. 2021, Hepatology (*In review, Middle author*)

#### Future
- &lt;mark&gt;&lt;b&gt;MetaboSPAN: Network-Based Approach for Functional Interpretation
  of Metabolomic Data&lt;/b&gt;&lt;/mark&gt;
- &lt;mark&gt;&lt;b&gt;RaMP 2.0: update to the RaMP pathway database&lt;/b&gt;&lt;/mark&gt;
]

---
# Metabolomics for biomedical research

&lt;img src="img/Metabolomics_overview.png" width="1200px" /&gt;

---

# Biological pathways

- Pathways are a collection of transcripts, proteins, and/or
  metabolites (analytes) with a related biological function
- Example: **Glycolysis** is a chain of 10 enzyme-catalyzed reactions
  where glucose is converted to pyruvate
.center[
&lt;img src="img/Glycolysis.jpeg" width="500px" /&gt;
&lt;/br&gt;
.tiny[https://www.thoughtco.com/steps-of-glycolysis-373394]
]

---

# Biological pathway databases
| Name            | # metabolites | Other features                                    |
|----------------|--------------|--------------------------------------------------|
| HMDB/SMPDB      | &gt;114,000      | Reactions, chemical class, spectra, ontologies    |
| KEGG            | &gt;18,000       | Reactions, Pathway hierarchy (BRITE)              |
| Reactome        | 1,856         | Interactive "Google Maps" pathway explorer        |
| Wikipathways    | 3,133         | Community-driven                                  |
| MetaCyc         | 16,313        | Highly curated                                    |
| PathBank        | 78,488        | Highly recent, contains many novel lipid pathways |

---

# Relational database of Metabolic Pathways (RaMP)
.pull-left[
- Multiomic pathway mySQL database integrating
information from **KEGG**, **HMDB**, **WikiPathways** and **Reactome** 
- Currently contains pathway information for &gt; 13,000 metabolites and &gt;14,000 
  transcripts, totalling 51,526 pathways and 536,245 associations
- Additional information includes chemical structures, chemical
classes, reactions, and ontologies
]

.pull-right[
&lt;/br&gt;
&lt;/br&gt;
&lt;img src="img/RaMP_contents.png" width="600px" /&gt;
]
---

# Using RaMP 2.0

.center[
&lt;img src="img/RaMP_interface.png" width="900px" /&gt;
]

---

# Pathway redundancy

.pull-left[
&lt;div class="figure"&gt;
&lt;img src="img/RaMP_pathway_overlap2.svg" alt="Overlap in metabolites making up pathways in RaMP. Color represents Jaccard index. Purple is high overlap, teal is low." width="450px" /&gt;
&lt;p class="caption"&gt;Overlap in metabolites making up pathways in RaMP. Color represents Jaccard index. Purple is high overlap, teal is low.&lt;/p&gt;
&lt;/div&gt;
]

.pull-right[
- Pathways often share sub-processes, resulting in functional redundancy
- This causes collinearity in pathway analysis results, making interpretation difficult
- Heatmap shows high overlap in pathway constituent metabolites,
particularly within the same databases ]

---

# Pathway overlap clustering

.center[
&lt;img src="img/Pathway_clustering.svg" width="1100px" /&gt;
]

---

# Other issues with pathway analysis

.pull-left[

![](index_files/figure-html/unnamed-chunk-9-1.png)&lt;!-- --&gt;
]

.pull-right[
- Lack of pathway annotations for metabolites (see left)
  + .small[Testing for enrichment of other annotations with better coverage can increase the number of metabolites we can incorporate into analysis]
- Uncertainty in metabolite identification
  + .small[If we treat our panel as a sample rather than a comprehensive snapshot of the metabolome, we can improve reproducibility
]
]

---

# MetaboSPAN

.center[
&lt;img src="img/MetaboSPAN_Schematic.png" width="900px" /&gt;
]

---

# Validating MetaboSPAN

.center[
&lt;img src="img/Validation_schematic.png" width="900px" /&gt;
]

---

# Pathway analysis methods
.small[
| Class                        | Pros  | Cons | Representative      |
|------------------------------|---|---------|---------------------|
| Over-representation analysis | Simple to implement, easy to interpret  |Depends on choice of background, ignores pathway overlap         | Fisher's exact test |
| Functional class scoring     | Self-contained hypothesis (no background)  | Hypothesis interpretation difficult, more challenging to implement | Globaltest          |
| Topological analysis         | Leverages graph theory and known pathway topology to improve analysis  | Graph-level annotations are not always available, challenging to implement        | NetGSA              |
| FELLA                        | Can enrich for reactions and pathways  | Only runnable on KEGG annotations   | FELLA               |
]

---

# Significant pathways in 500 random data sets
.panelset[
.panel[.panel-name[All methods]
.center[
&lt;img src="img/Null_model1.png" width="1000px" /&gt;
]
]

.panel[.panel-name[Different MetaboSPAN cutoffs]
.center[
&lt;img src="img/Null_model2.png" width="800px" /&gt;
]
]
]

---

# Recovery of altered pathways

.panelset[
.panel[.panel-name[Figure]
.center[
&lt;img src="img/Known_positivefigure.png" width="750px" /&gt;
]
]
.panel[.panel-name[Table]
.left-column[
&lt;img src="img/Known_positive_table.png" width="750px" /&gt;
]
.right-column[
- Fisher's with full database background and FELLA were the best at recovering "true positives"
- Fisher's with a custom background had the best false positive rate
]
]
]
---

# Robustness to sample size

.panelset[
.panel[.panel-name[Figure]
.center[
&lt;img src="img/Sample_partition_figure.png" width="1000px" /&gt;
]
]
.panel[.panel-name[Table]
.left-column[
&lt;/br&gt;
&lt;img src="img/Sample_partition_table.png" width="750px" /&gt;
]
.right-column[
- Fisher's with full database background and FELLA were the best at recovering "true positives"
- Fisher's with a custom background had the best false positive rate
]
]
]

---

# Similar findings in separate cohorts

.left-column[
&lt;/br&gt;
&lt;img src="img/Separate_cohorts table.png" width="1000px" /&gt;
]

.right-column[
- Significant pathways by each method were found in two datasets
  generated from same cohort
- MetaboSPAN improved the concordance of Fisher's results in both
background cases ]

---

# Pathway anaysis recommendations

1. When considering an algorithm, check how many significant pathways it finds in random data
2. When using Fishers, be aware of the tradeoffs and assumptions that come with each background selection
3. MetaboSPAN can improve the reproducibility and sensitivity of Fisher's results, with a cost to specificity
4. Consider using an ensemble approach to identify the most trustworthy altered pathways

---

# Dedifferentiated Liposarcoma 

.pull-left[
&lt;img src="img/DDLPS_prognosis.png" width="350px" /&gt;

.tiny[
Bill KLJ, Seligson ND, Hays JL, et al. Degree of Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma. Oncologist. 2019;24(7):989-996.
]
]

.pull-right[
- 20% of all soft tissue sarcoma diagnoses

- Some drugs (Dactinomycin, Doxorubicin) are used to treat
  liposarcoma, but they have unpredictable efficacy and toxicity.
  
- Prognosis depends on copy number of the MDM2 oncogene
]

---

# Targeting the p53-cholesterol synthesis axis

.pull-left[

&lt;img src="img/Atorvastatin_response.svg" width="800px" /&gt;

]

.pull-right[
- MDM2 modulates p53 expression as an antagonist
- Statins (mevalonate pathway inhibitors) have been associated with
  reduced mortality in mutant p53 cancers
- p53 downregulates transcriptional regulator of mevalonate pathway
- p53-null cell lines have been shown to withstand sterol deprived
  conditions better than WT

]

---

# Methods

.center[
&lt;img src="img/metabolite_methods.png" width="1000px" /&gt;
]

---

# Methods

.center[
&lt;img src="img/lipid_methods.png" width="1000px" /&gt;
]

---

# Impact of statin on DDLPS cell lipidome

.panelset[
.panel[.panel-name[MDM2 lower cells]

.pull-left[
![](index_files/figure-html/unnamed-chunk-23-1.png)&lt;!-- --&gt;
]

.pull-right[

- MDM2 low tumors have better prognosis
- MDM2 low cells responded to atorvastatin treatment
- 11 ceramides and 3 hexosylated ceramides were upregulated by atorvastatin treatment in MDM2 low cells

]
]

.panel[.panel-name[MDM2 higher cells]

.pull-left[
![](index_files/figure-html/unnamed-chunk-24-1.png)&lt;!-- --&gt;
]

.pull-right[
- MDM2 high tumors have worse prognosis
- MDM2 high cell lines did not respond to atorvastatin treatment
- Analyzing the lipidome of MDM2 high cells pre and post atorvastatin
treatment revealed only 4 lipids perturbed by treatment ]

]

]

---

# Sphingolipid metabolism as a therapeutic target

.center[
&lt;img src="img/sphingolipid_therapy.png" width="900px" /&gt;
]

---

# MDM2 status impact on ceramide levels

.panelset[
.panel[.panel-name[Metabolite panel]
.center[
![](index_files/figure-html/unnamed-chunk-26-1.png)&lt;!-- --&gt;

]
]


.panel[.panel-name[Lipid panel]
.pull-left[
![](index_files/figure-html/unnamed-chunk-27-1.png)&lt;!-- --&gt;
]

.pull-right[
&lt;/br&gt;
![](index_files/figure-html/unnamed-chunk-28-1.png)&lt;!-- --&gt;

]
]
]

---

# MetaboSPAN Results in Liposarcoma

&lt;img src="img/Network_figure_2.png" width="1000px" /&gt;

---

# In Conclusion

### 1. We characterized the metabolome/lipidome of a DDLPS model and identified sphingolipid metabolism as a potential therapeutic target

### 2. We developed RaMP, a comprehensive metabolomics functional annotations resource that harmonizes information from many large sources, and provides a convenient user interface, R package and mySQL database for ease of use

### 3. We developed and validated MetaboSPAN, a novel network-based pathway analysis algorithm that can compensate for uncertainty in identification and incomplete metabolome coverage

---

# Acknowledgements

.pull-left[
.small[
**Mathé Lab**
- Dr. Ewy Mathé, OSU/NCATS
- Tara Eicher, OSU/NCATS
- Kevin Ying, OSU
- Kyle Spencer, OSU/NCATS
- Dr. Garrett Kinnebrew, OSU


**Collaborators/Advisors**
- Dr. James Chen, OSU
- Dr. Kevin Coombes, OSU
- Dr. Zachary Abrams, OSU
- Dr. Lang Li, OSU
- Dr. Rachel Kopec, OSU

]]

.pull-right[
.small[
**Collaborators/Advisors**
- Dr. Tim Garrett, Florida State University
- Dr. Jeremy Koelmel Florida State University
- John Braisted, NCATS
- Jorge Neyra, NCATS
- NCATS informatics core

**Funding from**
- The OSU Clinical and Translational Research Informatics Training
Program (4T15LM011270-05)
- Systems and Integrative Biology training program (T32GM068412) ]]

---

# Questions?

.pull-left[
&lt;iframe src='https://gfycat.com/ifr/LongLateAcouchi' frameborder='0' scrolling='no' allowfullscreen width='480' height='390'&gt;&lt;/iframe&gt;&lt;p&gt;&lt;a href="https://gfycat.com/discover/question-gifs"&gt;from Question GIFs&lt;/a&gt; &lt;a href="https://gfycat.com/longlateacouchi-question-mark-confused-what-huh"&gt;via Gfycat&lt;/a&gt;&lt;/p&gt;
]

.pull-right[
- Slides link: https://andyptt21.github.io/Thesis_presentation_6_29_21

- RaMP link: https://rampdb.ncats.io/
]
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"countIncrementalSlides": false,
"seal": false,
"ratio": "16:9"
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();</script>
<style>
.logo {
  background-image: url(img/ncats-logo.png);
  background-size: contain;
  background-repeat: no-repeat;
  position: absolute;
  bottom: -85px;
  right: 1em;
  width: 150px;
  height: 128px;
  z-index: 0;
}
</style>

<script>
document
  .querySelectorAll(
    '.remark-slide-content' +
    ':not(.title-slide)' +
    // add additional classes to exclude here, e.g.
    // ':not(.inverse)' +
    ':not(.hide-logo)'
  )
  .forEach(el => {
    el.innerHTML += '<div class="logo"></div>';
  });
</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
